A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

In a randomized clinical trial, gemcitabine (GEM) was more effective than 5-fluorouracil (5-FU) in advanced pancreatic cancer patients. GEM and 5-FU have different mechanisms of action and their combination, from a theoretical point of view, could result in a higher activity. To test activity and fe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cascinu, S, Silva, R R, Barni, S, Labianca, R, Frontini, L, Piazza, E, Pancera, G, Giordani, P, Giuliodori, L, Pessi, M A, Fusco, V, Luporini, G, Cellerino, R, Catalano, G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 1999
Gaiak:
Regular Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363090/
https://ncbi.nlm.nih.gov/pubmed/10408405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690568
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak